Case Report
Published on 23 Jul 2024
Case report: A sustained survival benefit of third-line immunotherapy for refractory thymic carcinoma
in Cancer Immunity and Immunotherapy
![Case report: A sustained survival benefit of third-line immunotherapy for refractory thymic carcinoma](https://www.frontiersin.org/files/myhome article library/1326006/1326006_Thumb_400.jpg)
Case Report
Published on 23 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 23 Jul 2024
in Cancer Imaging and Image-directed Interventions
Original Research
Published on 23 Jul 2024
in Surgical Oncology
Original Research
Published on 23 Jul 2024
in Sustainable Food Processing
Original Research
Published on 23 Jul 2024
in Comparative and Clinical Medicine
Review
Published on 23 Jul 2024
in Renal Endocrinology
Opinion
Published on 23 Jul 2024
in Obesity
Original Research
Published on 23 Jul 2024
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Published on 23 Jul 2024
in Big Data, AI, and the Environment
Original Research
Published on 23 Jul 2024
in Adolescent and Young Adult Psychiatry
Original Research
Published on 23 Jul 2024
in Coronary Artery Disease
Original Research
Published on 23 Jul 2024
in Heart Failure and Transplantation
Original Research
Published on 23 Jul 2024
in Developmental Psychopathology and Mental Health
Original Research
Published on 23 Jul 2024
in Pediatric Urology
Original Research
Published on 23 Jul 2024
in Neuropharmacology
Original Research
Published on 23 Jul 2024
in Optics and Photonics